Efficacy and Visual Quality of Orthokeratology Lenses With Different Designs
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tianjin
-
Tianjin, Tianjin, China, 300020
- Tianjin Eye Hospital Opotometric Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age between 8 and 13 years.
- Subjective refraction under cycloplegia: spherical power between -4.00 D and
- 1.00 D, with cylindrical power≤ 1.50 D.
- Best-corrected visual acuity (BCVA) of ≥ 1.0 based on subjective refraction.
- Willing to participate in the clinical trial and provide signed informed consent.
Exclusion Criteria:
- One eye met the inclusion criteria
- Patients with systemic diseases causing immunocompromised or affecting orthokeratology
- There are other eye diseases that affect orthokeratology lens wearing, such as dacryocystitis, blepharitis, various inflammation, glaucoma, etc
- Abnormal cornea
- Previous corneal surgery or corneal trauma history
- Active keratitis (e.g., corneal infection)
- Patients with best corrected distance visual acuity of less than 5.0
- Patients with corneal flat curvature lower than 39.00D, or higher than 48.00D
- Patients with refractive instability
- Patients with overt strabismus
- The corneal epithelium showed obvious fluorescent staining, which was not suitable for patients wearing orthokeratology lenses
- Patients with dry eye are not suitable for orthokeratology
- Patients with corneal endothelial cell density less than 2000 cells /mm2
- Patients who had worn rigid contact lenses (including orthokeratology lenses) within the previous 30 days
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Experimental Group
Myopic children who need OK lens treatment
|
The orthokeratology lenses used in this study were Double Reservoir Lenses (DRL) manufactured by Precilens (Creteil, France).
The lenses feature a dual reverse-curve design with a back optic zone diameter (BOZD) of 5.0 mm.
|
|
Active Comparator: Control group
Myopic children who need OK lens treatment
|
The orthokeratology lenses used were Euclid lenses manufactured by Euclid Systems (Herndon, VA, USA).
These lenses feature a four-zone, five-curve design with a back optic zone diameter (BOZD) of 6.2 mm.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in axial length
Time Frame: The change of baseline and 1years
|
Axial length was measured with a biometer
|
The change of baseline and 1years
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of visual quality
Time Frame: Follow-up evaluations were conducted at baseline, and at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
The visual quality questionnaire used in this study was adapted from the questionnaire developed by Tilia et al.
The questionnaire comprises five categories with a total of nine questions, each accompanied by descriptive text and illustrative images to assist participants in providing their responses.
Participants were asked to select the image corresponding to each question, and their responses were converted into numerical scores ranging from 1 to 10, where a score of 1 represents the poorest visual quality.
|
Follow-up evaluations were conducted at baseline, and at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
|
Change of wavefront aberrations
Time Frame: Follow-up evaluations were conducted at baseline, and at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
Wavefront aberration data for the eye were obtained using a Hartmann-Shack wavefront sensor (i.Profiler plus, Carl Zeiss Co., Aalen, Germany).
The data were analyzed using Zernike polynomial decomposition to calculate the root mean square (RMS) values of total higher-order aberrations (HOAs), spherical aberration, coma aberration, trefoil, astigmatism, and fourth-order aberrations.
|
Follow-up evaluations were conducted at baseline, and at 1 day, 1 week, 1 month, 3 months, 6 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
|
Change of contract sensitivity
Time Frame: Follow-up evaluations were conducted at baseline, and at 1 week, 1 month, 3 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
Contrast sensitivity was assessed using the OPTEC 6500P contrast sensitivity tester (OPTEC 6500P, Stereo Optical Company, Inc., Chicago, USA) at five spatial frequencies: 1.5, 3, 6, 12, and 18 cycles/degree.
The contrast sensitivity scores were expressed in logarithmic units (base 10) following a logarithmic transformation.
|
Follow-up evaluations were conducted at baseline, and at 1 week, 1 month, 3 months, and 12 months after lens wear. The differences from baseline were calculated for each follow-up period.
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Tianjin Eye Hospital, Tianjin Eye Hospital Opotometic Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- Different Orthk lens
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.